Restricted accessResearch articleFirst published online 2019-8
RETRACTED: Two-year follow-up of a n-butyl-2-cyanoacrylate glue ablation for the treatment of saphenous vein insufficiency with a novel application catheter with guiding light
NicolaidesANAllegraCBerganJet al.
Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. İnt Angiol2008;
27: 1–59.
2.
JiaXMowattGBurrJMet al.
Systematic review of foam sclerotherapy for varicose veins. Br J Surg2007;
94: 925–936.
3.
BoneC.Tratamiento endoluminal de las varices con laser de diodo: studio prelimino. Rew Patol Vasc1999;
5: 35–46.
4.
NavarroLMinRJBoneC.Endovenous laser: a new minimally invasive method of treatment for varicose veins – preliminary observations using an 810 nm diode laser. Dermatol Surg2001;
27: 117–122.
5.
HashimotoOMiyazakiTHosokawaJet al.
A case of high-output heart failure caused by a femoral arteriovenous fistula after endovenous laser ablation treatment of the saphenous vein. Phlebology2015;
30: 290–292.
6.
OstlerAEHoldstockJMHarrisonCCet al.
Arterial false aneurysm in the groin following endovenous laser ablation. Phlebology2015;
30: 220–222.
7.
AlmeidaJIJavierJJMackayEGet al.
Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. Phlebology2015;
30: 397–404.
8.
MorrisonNGibsonKMcEnroeSet al.
Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg2015;
61: 985–994.
9.
BozkurtAKYilmazMF.A prospective comparison of a new cyanoacrylate glue and laser ablation for the treatment of venous insufficiency. Phlebology2016;
31: 106–113.
10.
YavuzTAcarANAydinHet al.A retrospective study of a new n-butyl-2-cyanoacrylate glue ablation catheter incorporated with application guiding light fort he treatment of venous insufficiency: twelve-month results. Vascular2018; 26(5): 547–555.
11.
StaniszewskaATambyrajaAAfolabiEet al.
The Aberdeen varicose vein questionnaire, patient factors and referral for treatment. EJVES2013;
46: 715–718.
12.
CarradiceDMazariFASamuelNet al.
Modelling the effect of venous disease on quality of life. Br J Surg2011;
98: 1089–1098.
13.
Beebe-DimmerJLPfeiferJREngleJSet al.
The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol2005;
15: 175–184.
14.
WangYMChengLFLiN.Histopathological study of vascular changes after intra-arterial and intravenous injection of N-butyl-2-cyanoacrylate. Chin J Dig Dis2006;
7: 175–179.
15.
AlmeidaJIMinRJRaabeRet al.
Cyanoacrylate adhesive for the closure of truncal veins: 60-day swine model results. Vasc Endovascular Surg2011;
45: 631–635.
16.
YasimAErogluEBozoglanOet al.
A new non-tumescent endovenous ablation method for varicose vein treatment: early results of N-butyl cyanoacrylate (VariClose®). Phlebology 2017; 32(3): 194–199.
17.
TokMTüydeşOYükselAet al.
Early-term outcomes for treatment of saphenous vein insufficiency with N-butyl cyanoacrylate: a novel, non-thermal, and non-tumescent percutaneous embolization technique. Heart Surg Forum2016;
19: 118–122.
18.
ÇalıkESArslanÜAyazFet al.
N-butyl cyanoacrylate in the treatment of venous insufficiency – the effect of embolisation with ablative polymerisation. Vasa2016;
45: 241–246.
